Brain Cancer
I am certainly happy to look at the model in the US around the right to try. I also want to update the House that we are appointing a national clinical lead for rare cancers, who will sit on the national cancer board. The benchmark is to improve outcomes and five-year survival rates for 14 less common cancers, including brain cancer. I know that Members will all hold us to account on that score.